SARASOTA, Fla. and MIAMI, Oct. 14, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience (“INVO”) (NASDAQ: INVO) today announced it has closed its merger with NAYA Biosciences, a company dedicated to increasing ...

INVO Fertility, formerly known as NAYA Biosciences (NASDAQ:NAYA) has announced a strategic separation of its fertility and oncology businesses, with the public company being renamed to INVO Fertility, ...

SARASOTA, Fla., Sept. 29, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (INVO) ("INVO" or the "Company") today announced that its special meeting of shareholders on September 29, 2023 (the "Special ...

AVENTURA, Fla. and SARASOTA, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- NAYA Biosciences Inc. ("NAYA"), a company which has recently signed a definitive merger agreement with INVO Bioscience to establish ...

SARASOTA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: NAYA), formerly known as NAYA Biosciences, Inc., a healthcare services fertility company focused on expanding access to ...

Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distribution of FDA-cleared INVOcell device Private company to operate as NAYA ...

SARASOTA, Fla., Nov. 5, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. INVO Bioscience Inc. has a very special announcement to ...